Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Professor Poggiolini seeks to vindicate himself in print:

This article was originally published in Clinica

Executive Summary

Professor Duilio Poggiolini is preparing to publish a book to free himself of "the undeserved demonisation, persecution and moral lynching to which I have been subjected". The book may be of interest to medical device manufacturers since Prof Poggiolini, who was jailed in the drug-corruption scandal of 1993, oversaw the Italian Health Ministry's medical devices department as former head of the medicines division. In a preliminary draft, he states: "I can affirm, without fear of denial, that the management of the pharmaceutical service in Italy over the past 20 years has been free of any deviation which might have placed private interests before that of the public." His book contains data on regulatory activities from the 1970s to the 1990s.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093787

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel